started · updated
CDSCO cancels FatX registration over misleading product claims
The Central Drugs Standard Control Organisation (CDSCO) has cancelled the registration of FatX due to discrepancies between the product’s approved label and claims made on the company’s official website.
The regulator found that the company marketed the product as a treatment to dissolve and reduce the size of fat cells. The CDSCO determined these assertions constitute drug claims rather than cosmetic claims, which are defined under the Drugs and Cosmetics Act, 1940, as products intended for cleansing, beautifying, or altering appearance.
The cancellation follows a show-cause notice issued on August 10, 2026, regarding violations of the Drugs and Cosmetics Act and Rule 36 of the Cosmetics Rules, 2020, which prohibits false or misleading claims. The company’s response to the notice was deemed inconclusive and unsatisfactory by the Licensing Authority.
Entities
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 3 SOURCES] The CDSCO cancelled the registration of FatX. desitalkchicago.com · newsable.asianetnews.com · www.news18.com
- [● 3 SOURCES] FatX marketed its product as a treatment for dissolving and reducing the size of fat cells on its website. desitalkchicago.com · newsable.asianetnews.com · www.news18.com
- [● 3 SOURCES] The firm submitted a response to the notice on September 1, 2026. desitalkchicago.com · newsable.asianetnews.com · www.news18.com
- [● 3 SOURCES] The CDSCO classified the fat cell claims as drug claims rather than cosmetic claims. desitalkchicago.com · newsable.asianetnews.com · www.news18.com
- [● 3 SOURCES] The Licensing Authority found the company's response to be inconclusive and unsatisfactory. desitalkchicago.com · newsable.asianetnews.com · www.news18.com
- [● 3 SOURCES] A show-cause notice was issued to the firm on August 10, 2026. desitalkchicago.com · newsable.asianetnews.com · www.news18.com